These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2130683)

  • 21. Pseudomonas respiratory infection in cystic fibrosis: a possible defect in opsonic IgG antibody?
    Fick RB; Reynolds HY
    Bull Eur Physiopathol Respir; 1983; 19(2):151-61. PubMed ID: 6871494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pseudomonas aeruginosa and cystic fibrosis: first colonization to chronic infection].
    Laurans M; Arion A; Fines-Guyon M; Regeasse A; Brouard J; Leclercq R; Duhamel JF
    Arch Pediatr; 2006 Oct; 13 Suppl 1():S22-9. PubMed ID: 17370393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Passive immunotherapy for treatment of endobronchitis in cystic fibrosis].
    Moss RB
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():42-6; discussion 47. PubMed ID: 8499750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice.
    Moser C; Johansen HK; Song Z; Hougen HP; Rygaard J; Høiby N
    APMIS; 1997 Nov; 105(11):838-42. PubMed ID: 9393554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Ratjen F
    Curr Opin Pulm Med; 2006 Nov; 12(6):428-32. PubMed ID: 17053493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Virulence factors in Pseudomonas aeruginosa: mechanisms and modes of regulation].
    Ben Haj Khalifa A; Moissenet D; Vu Thien H; Khedher M
    Ann Biol Clin (Paris); 2011; 69(4):393-403. PubMed ID: 21896403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenic mechanisms of chronic Pseudomonas aeruginosa infections in cystic fibrosis patients.
    Høiby N; Döring G; Schiøtz PO
    Antibiot Chemother (1971); 1987; 39():60-76. PubMed ID: 3118792
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of IgG subclass response to outer-membrane proteins in inhibiting adhesion of Pseudomonas aeruginosa to epithelial cells.
    Morrin M; Reen DJ
    J Med Microbiol; 1993 Dec; 39(6):467-72. PubMed ID: 8246267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of multiresistant Pseudomonas aeruginosa infection in cystic fibrosis: how to progress?].
    Burgel PR; Kanaan R
    Rev Mal Respir; 2010 May; 27(5):411-3. PubMed ID: 20569871
    [No Abstract]   [Full Text] [Related]  

  • 30. Cystic fibrosis respiratory infections: interactions between bacteria and host defence.
    Döring G
    Monaldi Arch Chest Dis; 1997 Aug; 52(4):363-6. PubMed ID: 9401367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.
    Döring G; Høiby N
    Infect Immun; 1983 Oct; 42(1):197-201. PubMed ID: 6413411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipathogenic properties of Lactobacillus plantarum on Pseudomonas aeruginosa: the potential use of its supernatants in the treatment of infected chronic wounds.
    Ramos AN; Cabral ME; Noseda D; Bosch A; Yantorno OM; Valdez JC
    Wound Repair Regen; 2012; 20(4):552-62. PubMed ID: 22642376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence of Pseudomonas aeruginosa elastase deficient mutant.
    Trancassini M; Ghezzi MC; Magni A; Nazzari C; Brenciaglia MI
    Microbiologica; 1990 Apr; 13(2):97-100. PubMed ID: 2112680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudomonas aeruginosa: biology, mechanisms of virulence, epidemiology.
    Vasil ML
    J Pediatr; 1986 May; 108(5 Pt 2):800-5. PubMed ID: 3009772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Determination of factors promoting, in vitro, the expression of adhesion of Pseudomonas aeruginosa to buccal cells].
    Agueda L; Marty N; Lapchine L; Chabanon G
    Pathol Biol (Paris); 1991 Mar; 39(3):171-6. PubMed ID: 1905007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scavenging of reactive oxygen species by tryptophan metabolites helps Pseudomonas aeruginosa escape neutrophil killing.
    Genestet C; Le Gouellec A; Chaker H; Polack B; Guery B; Toussaint B; Stasia MJ
    Free Radic Biol Med; 2014 Aug; 73():400-10. PubMed ID: 24929180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The virulence of Pseudomonas aeruginosa.
    Pollack M
    Rev Infect Dis; 1984; 6 Suppl 3():S617-26. PubMed ID: 6443764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis.
    Döring G; Goldstein W; Röll A; Schiøtz PO; Høiby N; Botzenhart K
    Infect Immun; 1985 Sep; 49(3):557-62. PubMed ID: 3928491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mucoid Pseudomonas aeruginosa infection in cystic fibrosis].
    Amitani R; Kuze F
    Nihon Rinsho; 1991 Oct; 49(10):2312-6. PubMed ID: 1749087
    [No Abstract]   [Full Text] [Related]  

  • 40. Detection of proteases of Pseudomonas aeruginosa in immune complexes isolated from sputum of cystic fibrosis patients.
    Döring G; Buhl V; Høiby N; Schiøtz PO; Botzenhart K
    Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):307-12. PubMed ID: 6440414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.